TIGECYCLINE is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is Tigecycline.
| Product ID | 16729-364_8541a1ed-2a2c-1fab-e053-2a91aa0a29d1 |
| NDC | 16729-364 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TIGECYCLINE |
| Generic Name | Tigecycline |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-03-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208744 |
| Labeler Name | Accord Healthcare Inc. |
| Substance Name | TIGECYCLINE |
| Active Ingredient Strength | 50 mg/10mL |
| Pharm Classes | Tetracycline-class Antibacterial [EPC],Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-03-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208744 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-28 |
| Marketing Category | NDA |
| Application Number | NDA208744 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-28 |
| Ingredient | Strength |
|---|---|
| TIGECYCLINE | 50 mg/10mL |
| SPL SET ID: | 70bf7ad3-ebf9-4fea-b3ac-26c537736d3d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0781-3481 | Tigecycline | Tigecycline |
| 16729-364 | TIGECYCLINE | TIGECYCLINE |
| 55150-228 | Tigecycline | Tigecycline |
| 60505-6098 | Tigecycline | TIGECYCLINE |
| 63323-960 | Tigecycline | Tigecycline |
| 70121-1647 | Tigecycline | Tigecycline |
| 70594-035 | Tigecycline | Tigecycline |
| 71288-019 | Tigecycline | Tigecycline |
| 0008-4990 | Tygacil | TIGECYCLINE |
| 0008-4994 | Tygacil | TIGECYCLINE |